Literature DB >> 30128698

Pharmacotherapy for Focal Seizures in Children and Adolescents.

Clare E Stevens1, Carl E Stafstrom2.   

Abstract

Focal-onset seizures are among the most common forms of seizures in children and adolescents and can be caused by a wide diversity of acquired or genetic etiologies. Despite the increasing array of antiseizure drugs available, treatment of focal-onset seizures in this population remains problematic, with as many as one-third of children having seizures refractory to medications. This review discusses contemporary concepts in focal seizure classification and pathophysiology and describes the antiseizure medications most commonly chosen for this age group. As antiseizure drug efficacy is comparable in children and adults, here we focus on pharmacokinetic aspects, drug-drug interactions, and side effect profiles. Finally, we provide some suggestions for choosing the optimal medication for the appropriate patient.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30128698     DOI: 10.1007/s40265-018-0959-6

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  160 in total

1.  Neural networks in human epilepsy: evidence of and implications for treatment.

Authors:  Susan S Spencer
Journal:  Epilepsia       Date:  2002-03       Impact factor: 5.864

Review 2.  Antiepileptic drugs for chronic non-cancer pain in children and adolescents.

Authors:  Tess E Cooper; Philip J Wiffen; Lauren C Heathcote; Jacqui Clinch; Richard Howard; Elliot Krane; Susan M Lord; Navil Sethna; Neil Schechter; Chantal Wood
Journal:  Cochrane Database Syst Rev       Date:  2017-08-05

Review 3.  Management of focal-onset seizures: an update on drug treatment.

Authors:  Svein I Johannessen; Elinor Ben-Menachem
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  The clinical pharmacology of traditional antiepileptic drugs.

Authors:  Frank J E Vajda; Mervyn J Eadie
Journal:  Epileptic Disord       Date:  2014-12       Impact factor: 1.819

Review 5.  Lacosamide.

Authors:  Pamela Doty; G David Rudd; Thomas Stoehr; Dirk Thomas
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

6.  Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1998-09       Impact factor: 5.864

Review 7.  Enzyme induction with antiepileptic drugs: cause for concern?

Authors:  Martin J Brodie; Scott Mintzer; Alison M Pack; Barry E Gidal; Charles J Vecht; Dieter Schmidt
Journal:  Epilepsia       Date:  2012-09-27       Impact factor: 5.864

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.

Authors:  Jon Soo Kim; Hunmin Kim; Byung Chan Lim; Jong-Hee Chae; Jieun Choi; Ki Joong Kim; Yong Seung Hwang; Hee Hwang
Journal:  Brain Dev       Date:  2013-08-12       Impact factor: 1.961

Review 10.  Gabapentin add-on for drug-resistant partial epilepsy.

Authors:  Sarah Al-Bachari; Jennifer Pulman; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-25
View more
  2 in total

1.  Social cognition in children and adolescents with epilepsy: A meta-analysis.

Authors:  Yang Sun; Jing Zhao; PanWen Zhao; Hui Zhang; JianGuo Zhong; PingLei Pan; GenDi Wang; ZhongQuan Yi; LiLi Xie
Journal:  Front Psychiatry       Date:  2022-09-15       Impact factor: 5.435

Review 2.  Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?

Authors:  Alec Aeby; Berten Ceulemans; Lieven Lagae
Journal:  Front Neurol       Date:  2022-03-07       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.